Page 285 - HIVMED_v21_i1.indb
P. 285

Page 3 of 8  Original Research


              percentages. Continuous variables were compared by using   Results
              the Wilcoxon rank-sum test as data were asymmetrically
              distributed. Categorical variables were compared by using   Descriptive data
              either the Chi-square test or Fisher’s exact test if there were   Ninety-six black African PLWH/DM (cases) and 192 black
              less than five observations in any cell. Pearson’s correlation   African HIV-uninfected patients with DM (controls) were
              coefficient assessed the correlation between HbA1c and   reviewed. People living with HIV and DM were significantly
              electrolytes. Multinomial logistic regression assessed factors   younger than HIV-uninfected patients with DM (median
              associated with electrolyte abnormalities. Linear regression   [IQR]: 46.5 [39–53.5] years vs. 56 [47–64] years;  p  <  0.001)
              analyses assessed the effect of measured covariates on   (Table 1). HIV-uninfected patients had a significantly longer
              electrolytes. Multivariable models were stratified by HIV   duration of DM compared with PLWH/DM (median [IQR]: 7
              status and were adjusted for gender, age, use of TDF, type of   [3–13] years vs. 5 [2–9] years; p = 0.006). People living with
              DM, duration of DM, duration of HIV, HbA1c and eGFR. A   HIV and DM had a median (IQR) duration of HIV of 7 (3–10)
              two-tailed value of  p < 0.05 was considered to indicate   years and 86 (89.58%) patients were on ART, which included
              statistical significance.                             65 (67.7%) patients on TDF (Table 1). Eighty-four (87.5%)
                                                                    PLWH/DM and 172 (89.58%) HIV-uninfected patients had
              Ethical consideration                                 type 2 DM. Seventy-three (76.0%) PLWH/DM and 153 (79.7%)
                                                                    HIV-uninfected patients with DM had an HbA1c > 7%, which
              Ethical approval to conduct the study was obtained from   was considered uncontrolled. The median (IQR) HbA1c
              the Biomedical Research and Ethics Committee (BREC) of   amongst PLWH/DM and HIV-uninfected patients with DM
              the University of KwaZulu-Natal (reference number     was  9.45%  (7.1%  –  11.45%)  and  9.70%  (7.35%  –  11.5%),
              BE576/18). Permission  was obtained from  Edendale    respectively (p = 0.836). An eGFR less than 60 mL/min/1.73m
                                                                                                                   2
              hospital to utilise the DM clinic datasheet for data   was present in 12 (12.5%) PLWH/DM and 24 (12.5%) HIV-
              collection.                                           uninfected patients with DM, respectively (Table1).
              TABLE 1: Demographic and clinical characteristics of people living with human immunodeficiency virus and diabetes mellitus, and human immunodeficiency virus-
              uninfected patients with diabetes mellitus.
              Parameter                          PLWH/DM (n = 96)            HIV-uninfected patients with DM (n = 192)  p
                                           n          %         IQR           n         %          IQR
              Age (years), median         46.5        -        39–53.5       56          -        47–64     < 0.001
              Gender                                                                                         1.000
              Female                      66         68.75       -           132       68.75        -
              Male                        30         31.25       -           60        31.25        -
              Duration of DM (years), median  5       -         2–9           7          -        3–13       0.006
              Duration of HIV (years), median  7      -         3–10          -          -          -         -
              Duration on ART (years), median  6      -         2–9           -          -          -         -
              Sodium (mmol/L), median     140         -       136.5–142      140         -       138–142     0.072
              Potassium (mmol/L), median  4.35        -       3.90–4.70      4.3         -       3.90–4.70   0.903
              Calcium (mmol/L), median    2.24        -       2.18–2.30      2.29        -       2.20–2.36   0.001
              Phosphate (mmol/L), median  1.03        -       0.91–1.21      1.08        -       0.93–1.23   0.406
              HbA1c (%), median           9.45        -        7.1–11.5      9.7         -       7.35–11.50  0.836
              HbA1c > 7%                  73         76.04       -           153       79.69        -        0.543
              eGFR < 60 mL/min/1.73m 2    12         12.5        -           24         12.5        -        1.000
              Diabetes type                                                                                  0.691
              Type 1                      12         12.5        -           20        10.41        -
              Type 2                      84         87.5        -           172       89.58        -
              Sodium                                                                                         0.457
              Hyponatraemia               18         18.75       -           26        13.54        -
              Hypernatraemia               2         2.08        -            7         3.65        -
              Potassium                                                                                      0.851
              Hypokalaemia                 6         6.25        -           15         7.81        -
              Hyperkalaemia                8         8.33        -           19         9.90        -
              Calcium                                                                                        0.292
              Hypocalcaemia                30        31.25       -           44        22.91        -
              Hypercalcaemia               1         1.04        -            3         1.56        -
              Phosphate                                                                                      0.959
              Hypophosphataemia            5         5.21        -           12         6.25        -
              Hyperphosphataemia           6         6.25        -           12         6.25        -
              On ART                       86        89.58       -            -          -          -         -
              On TDF ART                   65        67.71       -            -          -          -         -
              Source: Edendale Hospital diabetes clinic datasheet
              PLWH/DM,  people  living  with  human  immunodeficiency  virus  and  diabetes  mellitus;  HIV,  human  immunodeficiency  virus;  DM,  diabetes  mellitus;  IQR,  interquartile  range;  HbA1c,  glycated
              haemoglobin; eGFR, estimated glomerular filtration rate; ART, antiretroviral therapy; TDF, tenofovir.

                                           http://www.sajhivmed.org.za 277  Open Access
   280   281   282   283   284   285   286   287   288   289   290